Vers une évaluation globale du risque fracturaire

Kanis, 2002, A new approach to the development of assessment guidelines for osteoporosis, Osteoporos. Int., 13, 527, 10.1007/s001980200069 Kanis, 2002, Diagnosis of osteoporosis and assessment of fracture risk, Lancet, 359, 1929, 10.1016/S0140-6736(02)08761-5 1998 Kanis, 2001, Ten year probabilities of osteoporotic fractures according to BMD and diagnostic thresholds, Osteoporos. Int., 12, 989, 10.1007/s001980170006 Kanis, 2002, Intervention thresholds for osteoporosis, Bone, 31, 26, 10.1016/S8756-3282(02)00813-X Kanis, 2005, Intervention thresholds for osteoporosis in the UK, Bone, 36, 22, 10.1016/j.bone.2004.08.018 Kanis, 2005, Intervention thresholds for osteoporosis in men and women: a study based on data from Sweden, Osteoporos. Int., 16, 6, 10.1007/s00198-004-1623-4 Delmas, 2005, Treatment of patients with postmenopausal osteoporosis is worthwhile. The position of the International Osteoporosis Foundation, Osteoporos. Int., 16, 1, 10.1007/s00198-004-1813-0 Kanis, 2004, A meta-analysis of previous fracture and subsequent fracture risk, Bone, 35, 375, 10.1016/j.bone.2004.03.024 Kanis, 2004, A family history of fracture and fracture risk: a meta-analysis, Bone, 35, 1029, 10.1016/j.bone.2004.06.017 Kanis, 2005, Smoking and fracture risk: a meta-analysis, Osteoporos. Int., 16, 155, 10.1007/s00198-004-1640-3 De Laet, 2005, Body mass index as a predictor of fracture risk: a meta-analysis, Osteoporos. Int., 16, 1330, 10.1007/s00198-005-1863-y Kanis, 2004, A meta-analysis of prior corticosteroid use and fracture risk, J. Bone Miner. Res., 19, 893, 10.1359/JBMR.040134 Looker, 2000, Clinical use of biochemical markers of bone remodeling: current status and future directions, Osteoporos. Int., 11, 467, 10.1007/s001980070088 Delmas, 2000, The use of biochemical markers of bone turnover in osteoporosis, Osteoporos. Int., 11, S2, 10.1007/s001980070002 Dargent-Molina, 1996, Fall-related factors and risk of hip fracture: the EPIDOS prospective study, Lancet, 348, 145, 10.1016/S0140-6736(96)01440-7 Cummings, 1995, Risk factors for hip fracture in white women, N. Engl. J. Med., 332, 767, 10.1056/NEJM199503233321202 Black, 2006, Developing better economic models of osteoporosis: considerations for the calculation of the relative risk of fracture, Value Health, 9, 54, 10.1111/j.1524-4733.2006.00081.x Dargent-Molina, 2006, Identification of women at increased risk of osteoporosis: no need to use different screening tools at different ages, Maturitas, 54, 55, 10.1016/j.maturitas.2005.08.007 McClung, 2001, Effect of risedronate on the risk of hip fracture in elderly women, N. Engl. J. Med., 344, 333, 10.1056/NEJM200102013440503 Schott, 2001, The effect of risedronate on the risk of hip fracture in elderly women, N. Engl. J. Med., 344, 1721 Black, 2001, An assessment tool for predicting fracture risk in postmenopausal women, Osteoporos. Int., 12, 519, 10.1007/s001980170072 Kanis, 2006, Letter, Osteoporos. Int., 17, 493, 10.1007/s00198-005-2037-7 Jonsson, 1999, Effect and offset of effect of treatments for hip fracture on health outcomes, Osteoporos. Int., 10, 193, 10.1007/s001980050215 Dargent-Molina, 2002, Use of clinical risk factors in elderly women with low bone mineral density to identify women at higher risk of hip fracture: The EPIDOS Prospective Study, Osteoporos. Int., 13, 593, 10.1007/s001980200078 Kanis, 2005, Assessment of fracture risk, Osteoporos. Int., 16, 581, 10.1007/s00198-004-1780-5 Dargent-Molina, 2005, A triage strategy based on clinical risk factors for selecting elderly women for treatment or bone densitometry: the EPIDOS prospective study, Osteoporos. Int., 16, 898, 10.1007/s00198-004-1781-4 Johansson, 2004, Optimization of BMD measurements to identify high risk groups for treatment--a test analysis, J. Bone Miner. Res., 19, 906, 10.1359/jbmr.2004.19.6.906